Literature DB >> 20500149

Recent progress in chemically modified siRNAs.

M Gaglione1, A Messere.   

Abstract

RNA interference technology has become a powerful laboratory tool to study gene function. Small interfering RNAs (siRNAs) have provided unprecedented opportunities for the development of new therapeutics in human diseases. Unfortunately, siRNA duplexes are not optimal drug-like molecules. The problems for their effective application are fundamentally delivery, stability and off-target effects. Chemical modification provides solutions to many of the challenges facing siRNA therapeutics. In this review, we recapitulate and discuss the development of the latest described chemical modifications of siRNAs, with a special focus on novel chemical modifications of siRNA structure, architecture and siRNA conjugates.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20500149     DOI: 10.2174/138955710791384036

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  25 in total

Review 1.  Effect of surface properties on liposomal siRNA delivery.

Authors:  Yuqiong Xia; Jie Tian; Xiaoyuan Chen
Journal:  Biomaterials       Date:  2015-12-02       Impact factor: 12.479

Review 2.  Small-interfering RNAs (siRNAs) as a promising tool for ocular therapy.

Authors:  A Guzman-Aranguez; P Loma; J Pintor
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

3.  SMEpred workbench: A web server for predicting efficacy of chemicallymodified siRNAs.

Authors:  Showkat Ahmad Dar; Amit Kumar Gupta; Anamika Thakur; Manoj Kumar
Journal:  RNA Biol       Date:  2016-09-07       Impact factor: 4.652

4.  Selection and optimization of asymmetric siRNA targeting the human c-MET gene.

Authors:  Seul-gi Jo; Sun Woo Hong; Jae Wook Yoo; Chang Han Lee; Sera Kim; Soyoun Kim; Dong-ki Lee
Journal:  Mol Cells       Date:  2011-11-03       Impact factor: 5.034

Review 5.  Progress toward in vivo use of siRNAs-II.

Authors:  Garrett R Rettig; Mark A Behlke
Journal:  Mol Ther       Date:  2011-12-20       Impact factor: 11.454

Review 6.  High-density lipoproteins for the systemic delivery of short interfering RNA.

Authors:  Kaylin Marie McMahon; Colby Shad Thaxton
Journal:  Expert Opin Drug Deliv       Date:  2013-12-09       Impact factor: 6.648

Review 7.  Vigilance and validation: Keys to success in RNAi screening.

Authors:  Frederic D Sigoillot; Randall W King
Journal:  ACS Chem Biol       Date:  2010-12-28       Impact factor: 5.100

Review 8.  RNAi-based therapeutic strategies for metabolic disease.

Authors:  Michael P Czech; Myriam Aouadi; Gregory J Tesz
Journal:  Nat Rev Endocrinol       Date:  2011-04-19       Impact factor: 43.330

9.  A simple Bayesian estimate of direct RNAi gene regulation events from differential gene expression profiles.

Authors:  Paul A Wilson; Mathew Plucinski
Journal:  BMC Genomics       Date:  2011-05-20       Impact factor: 3.969

10.  RNAi Screening of the Glucose-Regulated Chaperones in Cancer with Self-Assembled siRNA Nanostructures.

Authors:  Mayurbhai R Patel; Stephen D Kozuch; Christopher N Cultrara; Reeta Yadav; Suiying Huang; Uri Samuni; John Koren; Gabriela Chiosis; David Sabatino
Journal:  Nano Lett       Date:  2016-10-03       Impact factor: 11.189

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.